bpc-157 typical dose subcutaneous bpc 157 injury healing Dosing (Common Protocols) πΉ Oral / β’ 500 mcg daily β’ Duration: 6 weeks πΉ Intramuscular / Peritendinous β’ 1 mg daily β’ Duration: 6 weeks β οΈ Note: Not BPC-157: Benefits & Dosage Guide
Description
Brain 2016;139(11):29832993

Some patients may experience nausea or vomiting after receiving the medicine

Each small line typically represents one unit

Ingredients: Water, butylene glycol (1,3, butanediol), tocofersolan, hyaluronic acid, ethanol, caprylyl glycol, medium chain triglycerides, copper tripeptide-1 (GHK-Cu), highly purified phospholipids, natural mixed tocopherols, Psoralea corylifolia seed/leaf extract (Bakuchiol), Tetrahexyldecyl ascorbate, lavender essential oil, estriol, estradiol Other Ingredients: None
